EurekAlert! 優睿科

最新科学信息

Updates every hour. Last Updated: 22-Oct-2026 23:16 ET (23-Oct-2026 03:16 GMT/UTC)

13-Sep-2026
 

ADAURA八年更新：辅助osimertinib在切除的EGFR突变NSCLC中持续带来总生存获益

International Association for the Study of Lung Cancer
Reports and Proceedings
13-Sep-2026
 

Zidesamtinib在既往未接受TKI的晚期ROS1阳性NSCLC患者中显示93%缓解率

International Association for the Study of Lung Cancer
Reports and Proceedings
13-Sep-2026
 

PAPILLON研究：一线amivantamab联合化疗在EGFR外显子20插入突变阳性晚期NSCLC中显示迄今报道最长的总生存期

International Association for the Study of Lung Cancer
Reports and Proceedings
12-Sep-2026
 

III期MAVERICK试验支持单独脑MRI监测作为小细胞肺癌标准治疗策略 不进行预防性颅脑照射的MRI监测改善无认知失败生存，并显著减少严重治疗相关不良事件

International Association for the Study of Lung Cancer
Reports and Proceedings
12-Sep-2026
 

III期TAISHAN-302试验显示Tam-Peli显著改善复发性小细胞肺癌生存

International Association for the Study of Lung Cancer
Reports and Proceedings
12-Sep-2026
 

Sacituzumab Govitecan联合Pembrolizumab未达到PD-L1高表达转移性NSCLC一线治疗主要终点

International Association for the Study of Lung Cancer
Reports and Proceedings
12-Sep-2026
 

Pumitamig联合elfetabart drozuntecan在小细胞肺癌中显示令人鼓舞的早期活性 PD-L1 x VEGF-A双特异性抗体联合B7H3抗体药物偶联物首次报告数据显示，各剂量总体客观缓解率为70.4%

International Association for the Study of Lung Cancer
Reports and Proceedings
12-Sep-2026
 

延长tarlatamab给药间隔在既往治疗小细胞肺癌中显示一致的活性和安全性

International Association for the Study of Lung Cancer
Reports and Proceedings